The new blood test identifies the presence of anti-CdtB and anti-vinculin, both of which are indicative of diarrhea-prominent IBS, within 24 hours. The study featuring this data was published in the peer-reviewed journal PLOS ONE.
“Data from this study validates our long-held suspicion that IBS is caused by infection, by way of confirming anti-vinculin and anti-CdtB as blood-based biomarkers that provide a differential diagnosis of IBS,” said Mark Pimentel, MD, FRCPC, director of the Gastrointestinal Motility Program and Laboratory at Cedars-Sinai in Los Angeles.
More articles on gastroenterology:
FDA clears 3 GI/endoscopy devices in April
Getting down to business: 4 gastroenterologists on learning the other side of medicine
Virginia Mason joins lawsuit against Olympus America – 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.